CDPATH™ for Crohn Disease
Study Summary
This trial is testing a tool to help predict Crohn's disease complications and to aid discussions with doctors about the disease.
- Crohn Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 8 Secondary · Reporting Duration: Baseline, then every 6 months up to 36 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
CDPATH™
1 of 1
Experimental Treatment
200 Total Participants · 1 Treatment Group
Primary Treatment: CDPATH™ · No Placebo Group · Phase 4
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:About The Reviewer
Michael Gill - B. Sc.
First Published: October 24th, 2021
Last Reviewed: November 30th, 2022
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| Illinois | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| University of Chicago Medical Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How many prior treatments have patients received?
| 3+ | 100.0% |